CFO of Neurocrine Biosciences Inc (30-Year Financial, Insider Trades) Matt Abernethy (insider trades) sold 15,000 shares of NBIX on 05/07/2020 at an average price of $110.21 a share. The total sale was $1.7 million.
Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. Neurocrine Biosciences Inc has a market cap of $10.55 billion; its shares were traded at around $113.57 with a P/E ratio of 61.72 and P/S ratio of 12.33. GuruFocus has detected 1 severe warning sign with Neurocrine Biosciences Inc. .
CEO Recent Trades:
- CEO Kevin Charles Gorman sold 2,906 shares of NBIX stock on 04/24/2020 at the average price of $99.45. The price of the stock has increased by 14.2% since.
CFO Recent Trades:
- CFO Matt Abernethy sold 15,000 shares of NBIX stock on 05/07/2020 at the average price of $110.21. The price of the stock has increased by 3.05% since.
- CFO Matt Abernethy sold 1,741 shares of NBIX stock on 04/28/2020 at the average price of $102.49. The price of the stock has increased by 10.81% since.
- CFO Matt Abernethy sold 1,934 shares of NBIX stock on 04/24/2020 at the average price of $99.52. The price of the stock has increased by 14.12% since.
Directors and Officers Recent Trades:
- Chief Research Officer Dimitri E. Grigoriadis sold 8,682 shares of NBIX stock on 05/07/2020 at the average price of $105.44. The price of the stock has increased by 7.71% since.
- Director Stephen A Sherwin sold 17,687 shares of NBIX stock on 04/28/2020 at the average price of $99.39. The price of the stock has increased by 14.27% since.
- Chief Medical Officer Eiry Roberts sold 1,934 shares of NBIX stock on 04/24/2020 at the average price of $99.47. The price of the stock has increased by 14.18% since.
- Chief Regulatory Officer Malcolm Lloyd-smith sold 1,934 shares of NBIX stock on 04/24/2020 at the average price of $99.45. The price of the stock has increased by 14.2% since.
- Chief Legal Officer Darin Lippoldt sold 1,934 shares of NBIX stock on 04/24/2020 at the average price of $99.49. The price of the stock has increased by 14.15% since.
For the complete insider trading history of NBIX, click here
.
